Q2 2019 Holdings
Filed 2019-07-12 | 9 holdings | $343.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $200.1M | 4,248,888 | 58.3% |
| Veracyte, Inc.(VCYT) | Common Stock | 92337F107 | $68.7M | 2,410,815 | 20.0% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $34.6M | 3,102,929 | 10.1% |
| Audentes Therapeutics, Inc.(BOLDEUR) | Common Stock | 05070R104 | $21.0M | 553,916 | 6.1% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $9.7M | 2,215,384 | 2.8% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $3.9M | 543,753 | 1.1% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $3.6M | 4,492,975 | 1.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $1.5M | 101,855 | 0.4% |
| OpGen, Inc. | Common Stock | 68373L109 | $40.1K | 102,167 | 0.0% |